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Radiotherapy reduces the local relapse rate after pleuropneumonectomy of malig-
nant pleural mesothelioma (MPM). The optimal treatment technique with photons 
remains undefined. Comparative planning for intensity-modulated radiotherapy 
(IMRT) and volumetric-modulated arc therapy (VMAT) was performed. Six MPM 
patients with significant postoperative intrathoracic air cavities were planned with 
IMRT and VMAT. A dose comparison for the targets and organ at risks (OAR) 
was performed. Robustness was assessed in respect to the variation of target dose 
with change in volume of air cavities. VMAT reduced the dose to the contralateral 
lung by reducing the volume covered by 13 Gy and 20 Gy by a factor 1.8 and 2.8, 
in respect to IMRT (p = 0.02). Dose distribution with VMAT was the most stable 
technique in regard to postsurgical air cavity variation. For IMRT, V90, V95, and 
the minimal target dose decreased by 40%, 64%, and 12% compared to 29%, 47%, 
and 7% with VMAT when air cavity decreased. Two arcs compared to one arc 
decreased the dose to all the organs at risk (OAR) while leaving PTV dose cover-
age unchanged. Increasing the number of arcs from two to three did not reduce the 
dose to the OAR further, but increased the beam-on time by 50%. Using partial 
arcs decreased the beam-on time by 43%. VMAT allows a lower lung dose and 
is less affected by the air cavity variation than IMRT. The best VMAT plans were 
obtained with two partial arcs. VMAT seems currently the most suitable technique 
for the treatment of MPM patients when air cavities are remaining and no adaptive 
radiotherapy is performed.
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I. IntroductIon
Malignant pleural mesothelioma (MPM) is an aggressive tumor with a high mortality rate 
and a survival rate of 38% after two years and 15% after five years.(1) The role of RT after 
extrapleural pneumonectomy (EPP) is to reduce local failure.(2,3) The dose to the hemithorax is 
typically limited to 45 Gy with a boost to 55 Gy(2,4) due to the adjacent dose limiting structures, 
such as the lung, kidney, spinal cord, liver, and heart. However, the tumor control rates after 
EPP, chemotherapy, and radiotherapy remains poor.(5) In order to enhance tumor control, dose 
escalation is an option if dose conformity is improved (e.g., proton therapy has been proposed 
for dose escalation due to the low dose delivered to the contralateral lung, heart, and kidney).(6) 
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However, access to proton therapy (PT) remains limited and proton techniques are hampered by 
postsurgical air cavities. After EPP, the ipsilateral hemithorax contains variable amounts of air, 
which subsequently are replaced by fibrous tissue. These cavities decrease over time, reducing 
drastically the dose to the target for PT which would decrease tumor control and counteract 
any potential benefit of an eventual dose escalation.
In this study, an evaluation of a new RT technique, volumetric-modulated arc therapy (VMAT) 
was performed for the treatment of MPM patients. The optimal number of arcs and degree of 
rotation were evaluated for the treatment of MPM patients with VMAT. Postoperative IMRT 
and VMAT were compared in order to define potential advantages of each technique: dosimet-
ric benefit and treatment time. Another goal was to evaluate the dose variation of VMAT and 
IMRT in respect to the variation of air cavities in the resected lung, and to evaluate for which 
air cavity variation adaptive planning is required. This was evaluated in respect to the change 
of dose in the target.
 
II. MAtErIALS And MEtHodS
Between 2004 and 2011, 16 patients diagnosed with MPM were treated with external radio-
therapy at the Zurich University Hospital, Switzerland. All of these patients received preop-
erative chemotherapy followed by extrapleural pleuropneumonectomy (EPP) and modulated 
radiotherapy. Six of 16 patients had air cavities exceeding 100 cm3 when the treatment planning 
computer tomography (CT) was performed and were selected for the present study. All CTs 
have been performed in supine head-first position. Five patients were male and one female. 
Five patients presented with right-sided MPM and one patient with left-sided MPM. Two 
of these six patients were treated with VMAT and four patients were treated with IMRT. All 
patients were planned with IMRT and VMAT, two patients prospectively and four patients 
retrospectively. The comparison between IMRT and VMAT was based on dose distribution, 
treatment time, and robustness of the techniques in respect to the effect of variation of the air 
cavity on the dose distribution.
Target volume definition was obtained as described previously in detail.(5) All patients were 
planned and treated with 26 × 1.75 Gy (45.5 Gy) to the planning target volume two (PTV2) 
including a simultaneously integrated boost of 26 × 2.15 Gy (55.9 Gy) to the PTV1. Due to the 
difficulty of the algorithm to optimize correctly the dose in air cavity, a PTV2* was defined for 
evaluation purpose only as PTV2 without air cavity. 
A.  IMrt and VMAt treatment
The technique used for IMRT was described previously(6) and followed the recommendation 
from Allen et al.(7) 
The VMAT plans were performed with two clockwise arcs of 205° ranging from 180° to 25° 
for right-sided tumors and from 335° to 180° for left-sided tumors. The isocenter was placed 
in the middle of the PTV2. The partial-arc technique was used in order to avoid entrance dose 
to the contralateral lung. The collimator angles were set to 355° and 5°.
The patient with the PTV volume closest to the mean PTV volume of all six MPM patients 
was chosen to assess the optimal number of arcs and the rotation angle required to treat MPM 
patients. Plans with one, two, or three full arcs (360°) or partial arcs (205°) were performed 
in order to assess the optimal number of arcs and gantry rotation. When one arc was used, the 
collimator angle was set to 5°. If a second arc was added (respectively a third arc), the collima-
tor angle was set to 355° (respectively 10°).
B.  dose calculation and delivery
Calculation and optimization were performed for IMRT and VMAT using an inverse treatment 
planning system (HELIOS, Eclipse V8.9 with AAA 8.9.08 algorithm, Varian Medical System, 
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Palo Alto, CA). One patient was calculated with Acuros XB (Varian Medical System) in order to 
quantify the dose distribution difference between one of the most advanced algorithm (Acuros) 
and AAA, the algorithm used clinically.( 8) Treatments were delivered on a 6 MV photon linear 
accelerator (Trilogy, Varian Medical Systems) equipped with a Millennium multileaf collimator 
with 120 leaves. Patient positioning was verified with either cone-beam CT (CBCT) or with 
two orthogonal kV images.
Pretreatment dose verification was performed with a cylindrical PMMA phantom having two 
perpendicular planes of 1069 diodes (Delta4; ScandiDos Inc., Uppsala, Sweden). The verifica-
tion of the plan had to reach a gamma score of 95% (3% dose difference, 3 mm distance to 
agreement) before patient irradiation. 
c.  dose volume constraints, plan, and treatment comparison
The dose constraints chosen were published previously(6) and are summarized in Table 1. DVHs 
were calculated for the PTVs and OARs for each plan. Target dose distributions were evaluated 
according to the volume covered by 80%, (V80), 85% (V85), 90% (V90), 95% (V95) and 105% 
(V105) of the prescribed dose and to the minimal dose (D99) and maximal dose (D1). The dose 
to OARs were evaluated according to mean dose, and organ-specific tolerance levels such as 
the volume covered by 15 Gy (V15) for kidneys, maximal dose to the spinal cord (D1), and V5, 
V13, and V20 for contralateral lung.
(1,9,10)
The treatment time, as well as the number of monitor units needed for one fraction, were 
evaluated for IMRT and VMAT. 
d.  Air cavities
Air cavity volume changes within the ipsilateral hemithorax following pleuropneumonectomy 
were measured as a function of time on various postoperative control computed tomographies 
(CT), RT planning-CT. and CBCT.(6) The air cavity volumes ranged from 150 cm3 to 1276 cm3. 
The axial, sagittal, and coronal views from the patients are displayed on Fig. 1. The evaluation 
of the variations of D1, D99, V80, V85, V90, V95, V100, and V105 with decrease of the air cavity 
volumes for the PTV1 and PTV2* were performed for IMRT and VMAT. Therefore, the dose 
distribution calculated on the planning CT was recalculated on all control CTs. When cone-
beam CTs or lateral images where available, the resected lung density of the planning study 
Table 1. Dose objectives and mean dose-volume histogram results from six IMRT and corresponding VMAT plans, 
respectively. 
  Objectives IMRT VMAT p-testa
PTV1(V95) (%)   94.7±2.1 94.2±1.3 0.39
PTV1(V105) (%)   4.5±3.5 6.3±2.0 0.49
PTV1(D99) (%)  95 90.9±2.8 91.4±1.3 0.13
PTV1(D1) (%)  107 106.7±1.8 106.8±0.7 0.18
PTV2*(V95) (%)  95 94.8±3.0 95.3±2.4 0.38
PTV2*(V105) (%)  10 20.1±9.0 18.3±8.8 0.21
Lung mean dose (Gy) 8.5 5.2±0.9 4.6±1.5 0.23
Lung V5 (%)  50 32.4±18.3 40.8±13.6 0.23
Lung V13  (%)  20 6.1±1.8 3.3±1.4 0.02
Lung V20 (%)  10 2.5±1.2 0.9±1.1 0.02
Contralateral kidney mean dose (Gy) 12 3.6±1.2 3.8±1.8 0.47
Contralateral kidney V15 (%) 20 0 0 -
Ipsilateral kidney mean dose (Gy) 12 12.4±6.1 11.9±6.8 0.25
Ipsilateral kidney V15 (%) 20 28.2±18.6 31.5±20.0 0.06
Spinal cord Dmax (Gy) 50 43.0±3.2 44.1±4.0 0.42
Liver mean dose (Gy) 24 14.8±6.4 14.6±7.9 0.19
a Significance (p < 0.05)
Vx (%) = volume receiving ≥ X% of prescribed dose;  Dx (%) = dose received by X% of volume. 
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Fig. 1. Air cavities remaining in the resected lung at the date of the planning CT in the axial (left image), coronal (middle 
image), and sagittal (right image) view. Five patients had a right-sided MPM ((a), (b), (c), (e), (f)) and one patient had a 
left-sided MPM (d). The volume of the air cavities are 150 cm3 (a), 225 cm3 (b), 243 cm3 (c), 276 cm3 (d), 379 cm3 (e), 
and 1276 cm3 (f).
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was modified in respect to these images. The effect of the air cavity decrease on the OARs 
was small as observed in this study and also on a previous study.(6) Therefore, the OAR dose 
fluctuation and air cavity variation are not reported in this study.
E.  Statistics
Statistical analysis was performed using a paired t-test. A p-value of < 0.05 was accepted 
as significant. 
 
III. rESuLtS 
The dose distribution calculated with AAA or Acuros, showed similar results. Indeed, V90, V95, 
as well as the mean dose for the targets and air cavities, where within 1%. Therefore, all data 
presented were calculated with the algorithm, AAA, used clinically.
 A typical dose distribution for IMRT and VMAT are displayed in the axial, sagittal, and 
coronal view for one patient on Fig. 2. IMRT and VMAT covered PTV1 with the 95% of the 
prescribed dose, but the PTV2* was partially underdosed with IMRT. The dose to the spinal 
cord, contralateral lung, and heart is equivalent for this patient. A larger posterior dose from 
the PTV1 is observed for IMRT. This “hot spot” results from the intersection of the three 
dorsal fields. 
A.  target volumes
DVH parameters for IMRT and VMAT plans for targets and OARs are summarized in Table 1. 
These parameters where calculated for VMAT using two partial arcs of 205°. The dose distribu-
tion was normalized to 55.9 Gy at 100% of the mean dose to the PTV1. The difference in dose 
homogeneity, minimal dose and maximal dose in the PTV1 for IMRT and VMAT was small and 
not significant. Indeed, the mean difference for V95, V105, D1, and D99 was within 1.8% (p not 
significant). Regarding the PTV2*, VMAT increased the V95 by 0.5% and decreased V105 by 
Fig. 2. Typical dose distribution in axial sagittal and coronal planes for IMRT (left side) and VMAT (right side). Dose 
distribution is shown for the entire treatment to a total dose of 55.9 Gy to the PTV1 (red structure) and 45 Gy to the PTV2 
(green structure) for the patient having the PTV1 volume closest to the mean PTV1 volume of all six MPM patients. The 
volume of the air cavities was 379 cm3.
6  Krayenbuehl et al.: IMrt and VMAt therapy for mesothelioma 6
Journal of Applied clinical Medical Physics, Vol. 14, no. 4, 2013
1.8% (p not significant). V80, V85, and V90 for PTV2* were always larger than 98% for each 
IMRT and VMAT plans. Therefore, these values were not displayed on Table 1.
B.  oAr
Comparison data for OAR are summarized in Table 1. Both, IMRT, and VMAT were able 
to keep the dose to the OAR below the constraints fixed in Table 1, except for the ipsilateral 
kidney. The mean dose and V15 for the ipsilateral kidney, which is surrounded by the target, 
could not be kept below 12 Gy and 20%.  
The mean ipsilateral kidney dose and V15 were 12.4 Gy and 28.2 Gy (respectively) for 
IMRT, and 11.9% and 31.5% (respectively) for VMAT (p = 0.25 and 0.06). It was not possible 
to keep these values below our objectives of 12 Gy and 20% due to the target surrounding the 
ipsilateral kidney. For the contralateral kidney, both techniques were able to keep the mean 
dose far below the constraints of 12 Gy (3.6 Gy for IMRT and 3.8 Gy for VMAT, p = 0.47), 
and V15 was kept at 0% for IMRT and VMAT. The contralateral lung V5 increased by 8.4% 
with VMAT in respect to IMRT, but the mean dose, as well as V13 and V20  to the contralateral 
lung, were reduced by 0.6 Gy, 2.7%, and 1.6% (respectively) with VMAT. The difference 
reached significance only for V13 and V20 (p=0.02). The maximal spinal cord dose as well as 
the mean liver dose for IMRT and VMAT were very close to each other and the difference was 
not significant (p = 0.42 and 0.19).
c.  Mu and treatment time
The mean number of monitor units was drastically reduced from IMRT to VMAT by a factor 
4.2 from 2080 ± 414 MU for IMRT to 485 ± 82 MU for VMAT in order to deliver 2.15 Gy 
(p < 0.01). The time required to deliver the plan was around 10 minutes for IMRT and 4 min-
utes for VMAT. The beam-on time for VMAT depends on the number of monitor units, dose 
rate, gantry angle rotation, and gantry rotation speed. For all the plans performed with VMAT, 
the gantry rotation speed was always at its maximal speed, 4.8°/sec, and the dose rate was 
modulated accordingly. Therefore, in our case, the monitor units were not affecting the treat-
ment time for the delivery of the VMAT plans, but only the gantry rotation angle determined 
the beam-on time.  
d.  Air cavities
Air cavities on the planning CT are displayed in Fig. 1. The initial air cavity measured on the 
planning CT ranged from 150 cm3 to 1275 cm3. The air cavity remaining after EPP shrinks 
with time to disappear completely. The volume decrease can reach 220 cm3 in 12 days.(6) The 
decrease of V80, V85, V90, V95, V100, V105, D1, and D99 in planning situation with air cavities 
are displayed on Figs. 3 and 4. IMRT and VMAT were not affected by the change of the air 
cavity volumes in respect to V80. V85 decreased only for IMRT when the air cavity variation 
was larger than 880 cm3. A decrease up to 10.2% for V85 was observed when the air cavity 
Fig. 3. Impact of the air cavities volume variation on the PTV1 volume covered by ≥ X% of the prescribed dose (Vx). 
Data are derived from six MPM patients with air cavities larger than 100 cm3. 
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volume decreased by 1276 cm3. IMRT (respectively VMAT) V90 decreased when a variation 
larger than 310 cm3 (respectively 610 cm3) was observed. The decrease of V90 was up to 40.3% 
for IMRT and 9.4% for VMAT. A reduction of V95 for IMRT and VMAT was observed for air 
cavity variation ≥ 200 cm3. The decrease of V95 could reach 64.4% for IMRT and 29.2% for 
VMAT. A decrease ≥ 28% for V95 is observed for IMRT in comparison to VMAT for air cav-
ity reduction larger than 311 cm3. Concerning PTV2, similar results as for PTV1 have been 
observed when air cavity shrinks. V80 (respectively V85) was not affected by a change of air 
cavity for IMRT (respectively VMAT). Decrease larger than 20% of V100 was observed when 
air cavity decreases by 300 cm3 and 600 cm3 for IMRT and VMAT, respectively. 
A decrease of V100 and V105 was observed for IMRT and VMAT even for small volume shrink-
ing (150 cm3). This decrease reached 100% for IMRT when the air cavity volume decreases by 
310 cm3 for V105 and 842 cm
3 for V100. For VMAT, a maximal decrease of 47% for V100 and 
72% for V105 was observed.
The minimal dose and the maximal dose in the PTV1 as a function of the variation of the 
air cavities are displayed in Fig. 4. The minimal dose for IMRT decreased up to 12.4% and up 
to 6.9% for VMAT. The decrease of the maximal dose was more pronounced for IMRT with a 
decrease up to 6.1% and 1.7% for VMAT.
E.  optimal number of arcs for VMAt plans
DVH parameters and monitor units for plans performed with one, two, and three partial and 
full arcs are displayed in Table 2. These parameters have been calculated for the patient hav-
ing the PTV volume closest to the mean PTV volume. When one arc is used, a full rotation 
showed better results than a partial rotation. Indeed, the V95 for the PTV1 was increased from 
93.3% to 95.6% and V105 was decreased by 4.5% with the full-arc rotation. All OARs had a 
lower dose with the full-rotation arc, except for the maximal dose to the spinal cord. If two arcs 
are used instead of one arc, V95 and V105 for the PTV were slightly improved and the dose to 
all OARs was drastically reduced. The same observation was seen for the dose to the left and 
right kidneys, liver, heart, and maximal dose to the spinal cord. The difference between two 
arcs of 205° and two arcs of 360° was very small, with a small improvement for the partial 
arcs in respect to the lung dose. If the number of arcs is increased from two to three, there is a 
small benefit for V95 for the PTV1. For the OAR, slight deviation was observed between two 
and three partial- or full-arc rotation.  
The number of monitor units increased with the gantry rotation angle. The monitor units 
ranged from 251 for a partial arc (205° rotation) to 708 for three full rotations (3 × 360°). The 
difference of beam-on time between the partial-arc rotation and full-arc rotation was always 
43% in favor of the partial-arc rotation. Indeed, the gantry rotation speed was always at its 
Fig. 4. Impact of the air cavities volume variation on the minimal and maximal dose of PTV1 for IMRT and VMAT. The 
PTV1 minimal dose (D99) and maximal dose (D1) are defined as dose received by 99% and 1%, respectively, of the PTV1 
volume. Data are derived from six MPM patients with air cavities larger than 100 cm3. 
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maximal velocity, 4.8°/sec, during the rotation of the arcs for each plan. Therefore, the  treatment 
time was not affected by the number of monitor units but was proportional only to the rotation 
angle performed by the gantry. 
 
IV. dIScuSSIon
Improved technologies enhance dose conformity, and avoiding dose delivery to critical struc-
tures has opened ways to treat complex oncological situations, such as MPM after EPP.(11,12) 
The RT treatment of MPM patients is commonly performed with IMRT, with improved dose 
conformity and homogeneity to the target in comparison with 3D conformal radiotherapy (3D 
CRT).(5) However, a major drawback of IMRT is the treatment time. Treatment delivery is 
time-consuming due to the large number of fields which are usually doubled due to split field 
technologies. Furthermore, a large number of MUs is needed (2080 ± 414 MU). The introduc-
tion of VMAT reduced the number of MUs by a factor of 4.2, reducing the treatment time from 
10 minutes to 4 minutes. As reported previously,(11) the decrease in treatment time reduces patient 
motion during the treatment delivery and thus results in greater agreement between the dose 
planned and dose delivered. This reduction in treatment time will decrease the time in which 
the patient has to stay in an uncomfortable position on the back with arms above the head. 
Concerning the dose to the OAR, no major differences were seen between IMRT and 
VMAT, except for the lung. However, a reduction by a factor of 1.8 and 2.8 for V13 and V20, 
respectively, for the lung was observed for VMAT. This reduction of lung dose could decrease 
the risk of complication, such as radiation-induced pneumonitis, where rates larger than 40% 
have been reported.(12)
The dose conformity and homogeneity were not statistically different for IMRT and VMAT. 
This is in agreement with previously published data.(11) Nevertheless, the small difference 
between IMRT and VMAT concerning the target coverage and dose homogeneity on the plan-
ning CT does not imply an identical delivery of dose to the target during all treatment sessions. 
Indeed, air cavities remain in the chest after EPP. The air volume change during RT can be 
considerable.(6) This will have a direct impact on DVH parameters for IMRT and VMAT plans. 
Indeed, when reduction ≥ 311 cm3 of the air cavity occurs, V95–V105, D1, and D99 are drasti-
cally modified. The decrease of dose to the target can even reach 100% for IMRT for V100 and 
72% for VMAT. The reason comes from the fact that the air cavity volumes are always located 
Table 2. DVH parameters and monitor units for plans performed with one, two, and three partial and full arcs. The values 
are calculated for one patient with the PTV1 volume closest to the mean PTV1 volume from all six MPM patients.
 1 Partial 1 Full 2 Partial 2 Full 3 Partial 3 Full
 Arc Arc Arcs Arcs Arcs Arcs
V95 (PTV1) (%) 93.3 95.6 94.5 95.1 95.1 95.6
V105 (PTV1) (%) 6.6 2.1 2.2 1.8 2.0 1.9
V95 (PTV2*) (%) 95.8 96.0 96.5 96.4 97.4 97.4
Dmean ipsilat kidney (Gy) 10.8 10.6 6.4 6 6.6 6.2
V15 ipsilat. kidney (Gy) 27.7 23.2 8.5 8.4 12 9.3
Dmean contralat. kidney (Gy) 8.7 8.5 6 6.1 5.9 5.3
V15 contralat. kidney (Gy) 8.6 5 0 0 0 0
Dmean lung (Gy) 8.4 8.4 4.8 5.1 4.7 5
V5 Lung (%) 87.1 87.1 30.3 36.1 29 33.3
V13 Lung (%) 12.1 10.8 1.5 2.1 1.8 2
V20 Lung (%) 0 0 0 0 0 0
Dmean liver (Gy) 20.4 20.5 16.8 16.7 16.8 16.8
Dmean heart (Gy) 17.7 16.4 11 11.4 10.8 12.2
Dmax myelon (Gy) 37.4 41.3 35.4 36.8 34 36.3
Monitor Units 251 298 513 638 563 708
Vx (%) = volume receiving ≥ X% of prescribed dose; Dx (%) = dose received by X% of volume.
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on the ventral part of the resected lung. When the lung cavity is replaced by serofibrous tissue 
during treatment, dose distribution delivered with photons coming from the anterior direction 
will be most affected, and the proportion of photons coming from the anterior direction is more 
pronounced for IMRT than for VMAT. Therefore, a larger decrease of dose for IMRT in the 
target occurs when the air cavities disappear than for VMAT.
The overall decrease of dose coverage with decrease of air cavity is not a monotonic func-
tion, as observed on Fig. 3. These data are displayed for six MPM patients with air cavity 
larger than 100 cm3. The change of PTV1 dose coverage will be strongly influenced by the 
location of the PTV1. Indeed, the higher the proportion of photons depositing energy in the 
PTV1 going through air cavity before the PTV1, the higher the PTV1 will be affected by a 
change of air cavity.
A special concern comes with the decrease of air cavity volumes ≥ 200 cm3 reducing dose 
homogeneity of target volumes (Fig. 3(b)). Small air cavity decrease (< 200 cm3) will impact 
only on the high dose in the PTV (V105 and V100). The minimal dose and V95 will decrease by 
less than 2%.
If the air cavity volume decreases > 200 cm3 compared to the planning situation, cold spots 
will appear in the target volume. Monitoring of air cavities can be achieved with two orthogonal 
kV images taken prior RT or with a CBCT. When an air cavity volume decrease larger than 
200 cm3 is observed, a control planning CT might be helpful in order to assess the impact on 
the dose variation and the need for an eventual new treatment plan.
The dose distribution can be affected by the number of beams. Regarding VMAT, an 
improvement of the dose distribution was observed when two arcs are used instead of one arc. 
However, increasing the number of arcs from two to three did not lead to any further improve-
ment for partial- or full-arc rotation. When two arcs are chosen, partial-arc techniques harbor 
the advantage to avoid dose delivery to the remaining lung, and the beam-on time can further 
be reduced by more than 40% compared with the full-arc rotation. Therefore, two partial arcs 
seem to be most suitable in respect to treatment time and dose distribution.
 
V. concLuSIonS
VMAT using multiple partial arcs enhances the treatment quality with photons when compared 
to IMRT by reducing the dose of ionizing radiation to the remaining lung while saving treatment 
time and integral dose. VMAT dose distributions are less susceptible to changing air cavities 
than IMRT. It is recommended that patients having air cavity variation exceeding 200 cm3 be 
monitored attentively in order to consider adaptive replanning in case of structural changes 
during treatment.
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